• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治愈 HIV:癌症疗法的启示。

Curing HIV: lessons from cancer therapy.

机构信息

David Geffen School of Medicine at UCLA, UCLA Center for Clinical AIDS Research and Education (CARE Center), University of California, Los Angeles, CA 90035, USA.

出版信息

Curr Opin HIV AIDS. 2013 May;8(3):224-9. doi: 10.1097/COH.0b013e32835ef0a1.

DOI:10.1097/COH.0b013e32835ef0a1
PMID:23454863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3789644/
Abstract

PURPOSE OF REVIEW

Interest in finding a potential 'cure' for HIV has taken on greater interest and urgency since the report of an individual who underwent allogeneic stem cell transplant from a CCR5 delta 32 homozygote donor after high-dose chemotherapy for acute myeloid leukemia. The potential role of cancer chemotherapy and other cancer-directed treatment approaches is discussed in the context of their potential role in helping to eliminate HIV from the infected host.

RECENT FINDINGS

Cancer chemotherapy and other cancer-targeted agents have been used successfully in treating a variety of malignancies in both HIV-infected and HIV-uninfected individuals. Lessons learned from these strategies may be of importance in helping to define more effective ways of controlling and eliminating HIV as well. Application of these anticancer strategies to patients with HIV are beginning to be explored and may help determine their potential usefulness in this disease as well.

SUMMARY

Although cytotoxic chemotherapy is a crude and not particularly effective way of removing HIV latently infected cells and tissue reservoirs, several new approaches to targeting and controlling cancer proliferation may be of value in HIV cure research and may one day help to end this disease.

摘要

目的综述

自从报道一位急性髓细胞白血病患者在接受高剂量化疗后,接受了 CCR5 Δ32 纯合子供体的同种异体干细胞移植,从而治愈 HIV 后,人们对寻找 HIV 潜在“治愈方法”的兴趣变得更加浓厚,也更加紧迫。本文将讨论癌症化疗和其他针对癌症的治疗方法在帮助受感染宿主清除 HIV 方面的潜在作用。

最近的发现

癌症化疗和其他针对癌症的药物已成功用于治疗 HIV 感染者和 HIV 阴性者的多种恶性肿瘤。从这些策略中吸取的经验教训对于帮助确定更有效的控制和消除 HIV 的方法可能也很重要。开始探索将这些抗癌策略应用于 HIV 患者,这可能有助于确定它们在该疾病中的潜在用途。

总结

虽然细胞毒性化疗是一种清除潜伏感染 HIV 的细胞和组织储库的原始且效果并不特别理想的方法,但针对控制癌症增殖的几种新方法可能对 HIV 治愈研究有价值,并可能有朝一日有助于终结这种疾病。

相似文献

1
Curing HIV: lessons from cancer therapy.治愈 HIV:癌症疗法的启示。
Curr Opin HIV AIDS. 2013 May;8(3):224-9. doi: 10.1097/COH.0b013e32835ef0a1.
2
Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure.伦敦与柏林的经验:探寻功能性 HIV 治愈方法。
Front Immunol. 2021 May 27;12:688747. doi: 10.3389/fimmu.2021.688747. eCollection 2021.
3
CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.HIV 感染者接受 CCR5Δ32 纯合子脐带血异基因移植:病例报告。
Lancet HIV. 2015 Jun;2(6):e236-42. doi: 10.1016/S2352-3018(15)00083-1. Epub 2015 May 19.
4
Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradication.HIV-1 感染个体中的造血干细胞移植:临床挑战和病毒清除的可能性。
Curr Opin Oncol. 2013 Mar;25(2):180-6. doi: 10.1097/CCO.0b013e32835d814a.
5
Progress toward curing HIV infections with hematopoietic stem cell transplantation.通过造血干细胞移植治愈HIV感染的进展。
Clin Infect Dis. 2015 Jan 15;60(2):292-7. doi: 10.1093/cid/ciu766. Epub 2014 Oct 1.
6
Hematopoietic stem cell transplantation for HIV cure.用于治愈艾滋病病毒的造血干细胞移植
J Clin Invest. 2016 Feb;126(2):432-7. doi: 10.1172/JCI80563. Epub 2016 Jan 5.
7
Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV.癌症与 HIV-1 的交汇点:HIV 治愈之道。
Front Immunol. 2019 Oct 4;10:2267. doi: 10.3389/fimmu.2019.02267. eCollection 2019.
8
Cord blood transplantation for cure of HIV infections.脐带血移植治疗 HIV 感染。
Stem Cells Transl Med. 2013 Sep;2(9):635-7. doi: 10.5966/sctm.2012-0089. Epub 2013 Jul 24.
9
Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?HIV-1 感染患者的基因修饰造血干细胞移植:我们能否实现治愈?
Mol Ther. 2014 Feb;22(2):257-264. doi: 10.1038/mt.2013.264. Epub 2013 Nov 13.
10
Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed.迈向治愈 HIV-1 感染:新策略的开发带来的经验教训和待解之谜。
AIDS Rev. 2018;20(4):220-225. doi: 10.24875/AIDSRev.18000027.

引用本文的文献

1
Identifying a Minor Histocompatibility Antigen in Mauritian Cynomolgus Macaques Encoded by .鉴定. 编码的毛里求斯食蟹猕猴中的次要组织相容性抗原
Front Immunol. 2020 Oct 26;11:586251. doi: 10.3389/fimmu.2020.586251. eCollection 2020.
2
Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?从艾滋病突破的失败与成功案例中吸取的经验教训:我们离治愈艾滋病更近了吗?
Front Microbiol. 2020 Jan 31;11:46. doi: 10.3389/fmicb.2020.00046. eCollection 2020.
3
Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions.利用癌症治疗方法推进艾滋病治愈议程:现状与未来方向。
Drugs. 2015 Sep;75(13):1447-59. doi: 10.1007/s40265-015-0426-6.
4
Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.基于CD4设计的新型双特异性嵌合抗原受体,旨在增强抗HIV效力并缺乏HIV进入受体活性。
J Virol. 2015 Jul;89(13):6685-94. doi: 10.1128/JVI.00474-15. Epub 2015 Apr 15.
5
Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection.基于靶向杀伤感染细胞的艾滋病治愈方法:针对急性感染与慢性感染的不同策略。
Curr Opin HIV AIDS. 2015 May;10(3):207-13. doi: 10.1097/COH.0000000000000151.
6
HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.HIV-1潜伏:分子机制与治疗策略的最新进展
Viruses. 2014 Apr 14;6(4):1715-58. doi: 10.3390/v6041715.
7
Targeted cytotoxic therapy kills persisting HIV infected cells during ART.靶向细胞毒性疗法在抗逆转录病毒治疗期间杀死持续存在的HIV感染细胞。
PLoS Pathog. 2014 Jan;10(1):e1003872. doi: 10.1371/journal.ppat.1003872. Epub 2014 Jan 9.

本文引用的文献

1
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.伏立诺他治疗可打破抗逆转录病毒治疗患者的 HIV-1 潜伏。
Nature. 2012 Jul 25;487(7408):482-5. doi: 10.1038/nature11286.
2
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.
3
Role of PD-1 in HIV pathogenesis and as target for therapy.PD-1 在 HIV 发病机制中的作用及其作为治疗靶点。
Curr HIV/AIDS Rep. 2012 Mar;9(1):81-90. doi: 10.1007/s11904-011-0106-4.
4
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.嵌合抗原受体修饰的 T 细胞治疗慢性淋巴细胞白血病。
N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10.
5
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.罗米地辛治疗外周 T 细胞淋巴瘤患者的 2 期临床试验。
Blood. 2011 Jun 2;117(22):5827-34. doi: 10.1182/blood-2010-10-312603. Epub 2011 Feb 25.
6
Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs.靶向细胞毒疗法:为清除持续性 HIV 感染细胞储库而调整快速发展的抗癌范式。
Curr Opin HIV AIDS. 2011 Jan;6(1):80-5. doi: 10.1097/COH.0b013e3283412515.
7
Stem-cell gene therapy for the Wiskott-Aldrich syndrome.Wiskott-Aldrich 综合征的干细胞基因治疗。
N Engl J Med. 2010 Nov 11;363(20):1918-27. doi: 10.1056/NEJMoa1003548.
8
Stem cell transplantation for lymphoma patients with HIV infection.HIV 感染淋巴瘤患者的干细胞移植。
Cell Transplant. 2011;20(3):351-70. doi: 10.3727/096368910X528076. Epub 2010 Sep 27.
9
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.基因治疗人类β-地中海贫血后实现输血独立性和 HMGA2 激活。
Nature. 2010 Sep 16;467(7313):318-22. doi: 10.1038/nature09328.
10
Antibody-drug conjugates: targeted drug delivery for cancer.抗体药物偶联物:癌症的靶向药物递送。
Curr Opin Chem Biol. 2010 Aug;14(4):529-37. doi: 10.1016/j.cbpa.2010.06.170. Epub 2010 Jul 17.